Pulmonary aspergillosis complicating chronic septic granulomatous disease.Treatment with itraconazole and interferon gamma

Citation
P. Mulliez et al., Pulmonary aspergillosis complicating chronic septic granulomatous disease.Treatment with itraconazole and interferon gamma, REV MAL RES, 17(5), 2000, pp. 975-978
Citations number
15
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
REVUE DES MALADIES RESPIRATOIRES
ISSN journal
07618425 → ACNP
Volume
17
Issue
5
Year of publication
2000
Pages
975 - 978
Database
ISI
SICI code
0761-8425(200011)17:5<975:PACCSG>2.0.ZU;2-K
Abstract
A 20-year-old patient suffering from chronic granulomatous disease develope d pulmonary aspergillosis with thoracic wall invasion. Treatment with itrac onazole combined with 3-weekly injections of interferon gamma (INF gamma) i mproved the patient's general state of health within two months. Functional signs resolved totally and x-ray images continued to improve for 6 months. INF gamma was withdrawn after 11 months and was replaced with cotrimoxasol e. Itraconazole was continued in a long-term regimen. Four years after onse t of treatment, the clinical status of the patient remained satisfactory an d the radiological aspect was unchanged Pulmonary aspergillosis affects up to 40% of patients suffering from chroni c granulomatous disease. Mortality is high, to the order of 25%. The classi cal treatment is based on amphotericin B, but this case points out the sign ificant contribution of itraconazole as first-line therapy. This antimycoti c has been suggested for prophylaxis. The combined use of INF gamma can be discussed due to the uncertainties about its long-term effects and because of the requirement for 3-weekly injections. High cost is another important consideration.